Radioactive lipiodol takes aim at inoperable liver tumors
Disease control
Terminated
This phase II trial tests a targeted radiation therapy called 188Re-SSS lipiodol for people with liver cancer that cannot be surgically removed. The treatment delivers radiation directly to the tumor through the liver's blood vessels. The study aims to see how many patients' tumo…
Phase: PHASE2 • Sponsor: Center Eugene Marquis • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC